Xi Lin

999 total citations · 1 hit paper
17 papers, 754 citations indexed

About

Xi Lin is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Xi Lin has authored 17 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Xi Lin's work include Immune cells in cancer (4 papers), Advanced Breast Cancer Therapies (3 papers) and Bone health and treatments (3 papers). Xi Lin is often cited by papers focused on Immune cells in cancer (4 papers), Advanced Breast Cancer Therapies (3 papers) and Bone health and treatments (3 papers). Xi Lin collaborates with scholars based in United States, China and Spain. Xi Lin's co-authors include Damien M. Cronier, Rose T. Ajamie, Miriam Del Prado, Marı́a José Lallena, Edward M. Chan, Emiko L. Kreklau, Shufen Cai, Raquel Torres, Blake Lee Neubauer and Jamie Young and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Xi Lin

17 papers receiving 744 citations

Hit Papers

Preclinical characterization of the CDK4/6 inhibitor LY28... 2014 2026 2018 2022 2014 100 200 300 400

Peers

Xi Lin
Comparison fields: 5 of 74
  • Oncology 458
  • Pulmonary and Respiratory Medicine 384
  • Molecular Biology 200
  • Genetics 129
  • Rheumatology 101
Replace Khoi Chu with:
Khoi Chu United States
Aviva Goel United States
Jiangang Liu China
Hongyi Wang China
Ana Teresa Amaral Spain
Julie Godet France
Satoshi Kiyama Japan
Yingrong Lai China
R. Caputo Italy
Debra M. Sutkowski United States
Khoi Chu United States View profile →
Citations per field, relative to Xi Lin
Xi Lin · 1×
Citations per year, relative to Xi Lin
Xi Lin · 1×

Countries citing papers authored by Xi Lin

Since Specialization
Citations

This map shows the geographic impact of Xi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Lin more than expected).

Fields of papers citing papers by Xi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Lin. The network helps show where Xi Lin may publish in the future.

Co-authorship network of co-authors of Xi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Lin. A scholar is included among the top collaborators of Xi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Lin. Xi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 17
2 3
3 4
4 56
5 2
6 18
7 11
8 8
9 12
10 23
11 16
12 22
13 36
14
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine breakdown →
446
15 14
16 65
17
High throughput multiplexing phosphor retinoblastoma tumor suppressor protein (Rb) and cell cycle analysis using acuman technology.
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026